期刊文献+

中大剂量阿糖胞苷巩固治疗细胞遗传学低中危的年轻急性髓系白血病:124例单中心回顾性分析 被引量:8

Intermediate-high dose cytarabine consolidation therapy in younger adults with acute myeloid leukemia and favorable-intermediate cytogenetic risk:a retrospective study of 124 patients in a single Chinese hospital
原文传递
导出
摘要 为进一步明确中大剂量阿糖胞苷(Ara-C)巩固治疗在细胞遗传学低中危的年轻急性髓系白血病(AML)中的临床意义,我们回顾性分析了我院124例AML患者的长期疗效,比较分析中大剂量Ara-C巩固治疗中不同单次剂量及疗程数的疗效差异与不良反应,进一步探讨中大剂量Ara-C巩固治疗的安全性及应用前景。
作者 张仪 钱劼靖 王蕾 俞文娟 毛莉萍 佟红艳 孟海涛 钱文斌 金洁 Zhang Yi;Qian Jiejing;Wang Lei;Yu Wenjuan;Mao Liping;Tong Hongyan;Meng Haitao;Qian Wenbin;Jin Jie(The First Affiliated Hospital of Zhejiang University,Hangzhou 310003,China)
出处 《中华血液学杂志》 CAS CSCD 北大核心 2019年第5期429-431,共3页 Chinese Journal of Hematology
  • 相关文献

参考文献3

二级参考文献31

  • 1俞文娟,秘营昌,卞寿庚,张凤奎,孙晓明,周世勇,王建祥.中剂量阿糖胞苷诱导治疗成人急性髓系白血病[J].中华血液学杂志,2005,26(2):109-111. 被引量:6
  • 2张峰,贾金海.大剂量阿糖胞苷与甲氨蝶呤化疗对肾损害的探讨[J].中国医药,2006,1(2):87-88. 被引量:6
  • 3Deisseroth A, Farrell A, Justice R,et al. Toxicity of laromustineplus high-dose cytarabine in patients with relapsed acute myeloidleukemia. Blood, 2010 ,115(2) :430.
  • 4Neubauer A, Maharry K, Mr6zek K, et al. Patients with acute my-eloid leukemia and RAS mutations benefit most from postremissionhigh-dose cytarabine : a Cancer and Leukemia Group B study. JClin Oncol, 2008,26(28) :46034609.
  • 5Gorin NC, Labopin M, Frassoni F, et al. Identical outcome afterautologous or allogeneic genoidentical hematopoietic stem-cell trans-plantation in first remission of acute myelocytic leukemia carryinginversion 16 or t(8 ;21 ) : a retrospective study from the EuropeanCooperative Group for Blood and Marrow Transplantation. J ClinOncol, 2008,26( 19) :3183-3188.
  • 6Thomas X,Elhamri M, Raffoux E, et al. Comparison of high-dosecytarabine and timed-sequential chemotherapy as consolidation foryounger adults with AML in first remission : the ALFA-9802 study.Blood, 2011,118(7) :1754-1762.
  • 7Lowenberg B, Pabst T, Vellenga E, et al. Cytarabine dose for acutemyeloid leukemia. N Engl J Med, 2011,364(11) : 1027-1036.
  • 8Bonnet D,Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J].Nat Med,1997,3(7):730-737.
  • 9Fialkow PJ,Singer JW,Adamson JW,et al.Acute nonlympho- cytic leukemia:expression in cells restricted to granulocytic and monocytic differentiation[J].N Engl J Med,1979,301(1):1-5.
  • 10National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology:Acute Myeloid Leukemia,V.l.2015,Dec 3,2014.http:// guide.medlive.cn/guideline/7412.

共引文献30

同被引文献55

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部